Our findings could not rule out that the hypersensitivity of KMT2D-mutant HNSCC cells to PARP inhibitors was due to the defects in other DNA damage repair mechanisms by the inhibition of ATR, BRCA1 and POLQ. The gene discussed is POLQ; the disease is head and neck squamous cell carcinoma.